Article · 30 Sep 2025
Short communicationPublished 24 Apr 2021
Metabolic Reprogramming in Triple-Negative Breast Cancer: Covid 19
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The COVID-19 pandemic has necessitated the development of breast cancer treatment prioritisation policies, with patients with advanced disease, such as triple-negative breast cancer (TNBC), receiving top priority for clinical intervention. We summarise how COVID-19 has affected TNBC management so far and highlight areas where more data is required to fine-tune changing guidelines. TNBC management during the pandemic poses problems beyond the limits of overburdened healthcare systems, due to the immunocompromised state of most TNBC patients seeking treatment. During the COVID-19 outbreak, we performed a literature review of clinical recommendations for both primary and targeted TNBC therapeutic methods, noting improvements in treatment timing and drugs of choice.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in European Journal of Clinical Oncology.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalEuropean Journal of Clinical Oncology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Paola M Brown”
